OKYO Pharma Limited (OKYO)

OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	0.99	0.83	4.05	2.7	6.88	0.19
Cash & Short-Term Investments	0.99	0.83	4.05	2.7	6.88	0.19
Cash Growth	-75.60%	-79.56%	49.79%	-60.73%	3520.44%	-60.52%
Other Receivables	1.52	0.58	0.98	0.88	0.08	0.25
Receivables	1.52	0.58	0.98	0.88	0.08	0.26
Prepaid Expenses	0.32	0.13	0.17	0.71	0.02	0.01
Total Current Assets	2.83	1.54	5.2	4.3	6.97	0.46
Property, Plant & Equipment	0	0	0.01	0.01	0.1	0.02
Total Assets	2.83	1.54	5.2	4.3	7.08	0.48
Accounts Payable	9.61	6.13	2.31	0.74	0.21	0.48
Accrued Expenses	-	1.19	2.65	0.61	1.46	0.07
Short-Term Debt	0	-	2.22	-	-	-
Current Portion of Leases	-	-	-	-	0.03	0
Other Current Liabilities	0.45	0.1	0.07	-	-	0.02
Total Current Liabilities	10.05	7.42	7.26	1.35	1.7	0.57
Long-Term Leases	-	-	-	-	0.06	0.02
Total Liabilities	10.05	7.42	7.26	1.35	1.77	0.6
Additional Paid-In Capital	144.05	143.11	131.39	123.98	91.91	67.52
Retained Earnings	-145.2	-142.52	-125.7	-112.43	-99.4	-69.42
Comprehensive Income & Other	-6.07	-6.47	-7.74	-8.6	12.8	1.79
Shareholders' Equity	-7.23	-5.88	-2.05	2.95	5.31	-0.11
Total Liabilities & Equity	2.83	1.54	5.2	4.3	7.08	0.48
Total Debt	0	-	2.22	-	0.1	0.03
Net Cash (Debt)	0.99	0.83	1.83	2.7	6.78	0.16
Net Cash Growth	-46.16%	-54.82%	-32.23%	-60.16%	4023.42%	-65.84%
Net Cash Per Share	0.03	0.03	0.08	0.18	0.65	0.02
Filing Date Shares Outstanding	33.94	33.84	25.55	21.14	10.35	9.79
Total Common Shares Outstanding	33.94	33.34	25.52	21.14	10.35	9.79
Working Capital	-7.23	-5.88	-2.06	2.94	5.27	-0.12
Book Value Per Share	-0.21	-0.18	-0.08	0.14	0.51	-0.01
Tangible Book Value	-7.23	-5.88	-2.05	2.95	5.31	-0.11
Tangible Book Value Per Share	-0.21	-0.18	-0.08	0.14	0.51	-0.01
Machinery	0.01	0.01	0.02	0.01	0.01	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q